Cargando…
A Pilot Clinical Trial of Nitazoxanide in the Treatment of Chronic Hepatitis B
Chronic infection by the hepatitis B virus (HBV) has remained a major public health problem. To achieve an HBV cure, we will likely need to combine antivirals with different viral targets as well as immunotherapy. Here, we report data from a pilot proof‐of‐concept clinical trial of nitazoxanide in t...
Autores principales: | Rossignol, Jean‐François, Bréchot, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546020/ https://www.ncbi.nlm.nih.gov/pubmed/31168509 http://dx.doi.org/10.1002/hep4.1339 |
Ejemplares similares
-
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
por: Rossignol, Jean-François, et al.
Publicado: (2022) -
Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
por: Rossignol, Jean-François
Publicado: (2016) -
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
por: Rossignol, Jean-François
Publicado: (2014) -
Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika
por: Cao, Rui-Yuan, et al.
Publicado: (2017) -
The Modulation of Cholesterol Metabolism Is Involved in the Antiviral Effect of Nitazoxanide
por: Fenizia, Claudio, et al.
Publicado: (2021)